Abstract
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the production of antiphospholipid antibodies (aPLs), which recognize and bind to plasma proteins connected to cell membrane phospholipids. Studies indicate that these antibodies, upon interacting with phospholipids, induce the release of neutrophil extracellular traps (NETs), structures that participate in the …